Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation
暂无分享,去创建一个
R. Leavitt | Valerie Teal | P. Ljungman | F. Marty | J. Butterton | R. Chemaly | W. Yeh | H. Wan | C. Badshah | V. Teal